Corona Remedies debuts with 35% premium

New Delhi: Making a remarkable market debut, shares of pharma firm Corona Remedies Ltd closed with a premium of over 35 per cent against the issue price of Rs 1,062 per share on Monday.

The stock started trading at Rs 1,452, a jump of 36.72 per cent from the issue price on the BSE. During the day, it surged 41.14 per cent to Rs 1,499 before settling at Rs 1,437.20, up 35.32 per cent.

At the NSE, shares listed at a premium of 38.41 per cent at Rs 1,470.